ABSORPTION OF PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE BY RAT INTESTINE

被引:5
|
作者
FURUKAWA, M
FRENKEL, RA
JOHNSTON, JM
机构
[1] UNIV TEXAS,SOUTHWESTERN MED CTR,DEPT BIOCHEM,DALLAS,TX 75235
[2] UNIV TEXAS,SOUTHWESTERN MED CTR,DEPT OBSTET GYNECOL,DALLAS,TX 75235
[3] UNIV TEXAS,SOUTHWESTERN MED CTR,CECIL H & IDA GREEN CTR REPROD BIOL SCI,DALLAS,TX 75235
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1994年 / 266卷 / 05期
关键词
HUMAN MILK; MACROMOLECULAR ABSORPTION; NECROTIZING ENTEROCOLITIS;
D O I
10.1152/ajpgi.1994.266.5.G935
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Platelet-activating factor acetylhydrolase (PAF-AH) is a 43-kDa protein that catalyzes the degradation and inactivation of this potent phospholipid mediator. PAF plays an important role in the pathogenesis of necrotizing enterocolitis (NEC), and the elevation of the plasma PAF-AH activity may be beneficial in the prevention of this disease. The activity of PAF-AH was transferred from the mucosal to the serosal fluid in intestinal sacs from neonatal rats. Translocation was highest on day 15, decreased by day 21, and disappeared by day 24. Greater transport of the enzyme was noted in the neonatal jejunum compared with duodenum or ileum. PAF-AH absorption in 15-day-old rats was decreased by the addition of inhibitors of energy production and by low temperature. We have, therefore, concluded that the enzyme transport is an energy-dependent process. It is suggested that PAF-AH found in milk may prove to be beneficial in the prevention of NEC by its translocation across the intestinal mucosa. The absorption of macromolecules in the neonate, in addition to providing a passive immunity, may also serve a protective role by inactivating certain proinflammatory agents, such as PAF.
引用
收藏
页码:G935 / G939
页数:5
相关论文
共 50 条
  • [1] ANTIINFLAMMATORY PROPERTIES OF A PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE
    TJOELKER, LW
    WILDER, C
    EBERHARDT, C
    STAFFORINI, DM
    DIETSCH, G
    SCHIMPF, B
    HOOPER, S
    LETRONG, H
    COUSENS, LS
    ZIMMERMAN, GA
    YAMADA, Y
    MCINTYRE, TM
    PRESCOTT, SM
    GRAY, PW
    [J]. NATURE, 1995, 374 (6522) : 549 - 553
  • [2] PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE IN HUMAN ERYTHROCYTES
    STAFFORINI, DM
    PRESCOTT, SM
    MCINTYRE, TM
    [J]. METHODS IN ENZYMOLOGY, 1991, 197 : 411 - 425
  • [3] PLATELET-ACTIVATING-FACTOR INDUCED ISCHEMIC BOWEL NECROSIS - THE EFFECT OF PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE
    FURUKAWA, M
    LEE, EL
    JOHNSTON, JM
    [J]. PEDIATRIC RESEARCH, 1993, 34 (02) : 237 - 241
  • [4] PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE IN ASTHMATIC AND EMPHYSEMATOUS PATIENTS
    LUO, SF
    WU, YJJ
    WEI, JS
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 162 - 162
  • [5] PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE IN HUMAN SEMINAL PLASMA
    LETENDRE, ED
    MIRON, P
    ROBERTS, KD
    LANGLAIS, J
    [J]. FERTILITY AND STERILITY, 1992, 57 (01) : 193 - 198
  • [6] PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE FROM HUMAN PLASMA
    STAFFORINI, DM
    MCINTYRE, TM
    PRESCOTT, SM
    [J]. METHODS IN ENZYMOLOGY, 1990, 187 : 344 - 357
  • [7] CATABOLISM OF PLATELET-ACTIVATING-FACTOR AND ITS ACYL ANALOG - DIFFERENTIATION OF THE ACTIVITIES OF LYSOPHOSPHOLIPASE AND PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE
    AARSMAN, AJ
    NEYS, FW
    VANDENBOSCH, H
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 200 (01): : 187 - 193
  • [8] HUMAN-PLASMA PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE - ASSOCIATION WITH LIPOPROTEIN PARTICLES AND ROLE IN THE DEGRADATION OF PLATELET-ACTIVATING-FACTOR
    STAFFORINI, DM
    MCINTYRE, TM
    CARTER, ME
    PRESCOTT, SM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1987, 262 (09) : 4215 - 4222
  • [9] PURIFICATION AND CHARACTERIZATION OF BOVINE BRAIN PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE
    HATTORI, M
    ARAI, H
    INOUE, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (25) : 18748 - 18753
  • [10] HUMAN PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE EXPRESSED IN XENOPUS OOCYTES
    YAMADA, Y
    STAFFORINI, DM
    FITZGERALD, LA
    ZIMMERMAN, GA
    MCINTYRE, TM
    PRESCOTT, SM
    [J]. CLINICAL RESEARCH, 1992, 40 (02): : A201 - A201